Literature DB >> 20130214

Distinct phenotype and function of NK cells in the pancreas of nonobese diabetic mice.

Hanna Brauner1, Marjet Elemans, Sara Lemos, Christian Broberger, Dan Holmberg, Malin Flodström-Tullberg, Klas Kärre, Petter Höglund.   

Abstract

Little is known about target organ-infiltrating NK cells in type 1 diabetes and other autoimmune diseases. In this study, we identified NK cells with a unique phenotype in the pancreas of NOD mice. Pancreatic NK cells, localized to the endocrine and exocrine parts, were present before T cells during disease development and did not require T cells for their infiltration. Furthermore, NK cells, or NK cell precursors, from the spleen could traffic to the pancreas, where they displayed the pancreatic phenotype. Pancreatic NK cells from other mouse strains shared phenotypic characteristics with pancreatic NK cells from NOD mice, but displayed less surface killer cell lectin-like receptor G1, a marker for mature NK cells that have undergone proliferation, and also did not proliferate to the same extent. A subset of NOD mouse pancreatic NK cells produced IFN-gamma spontaneously, suggesting ongoing effector responses. However, most NOD mouse pancreatic NK cells were hyporesponsive compared with spleen NK cells, as reflected by diminished cytokine secretion and a lower capacity to degranulate. Interestingly, such hyporesponsiveness was not seen in pancreatic NK cells from the nonautoimmune strain C57BL/6, suggesting that this feature is not a general property of pancreatic NK cells. Based on our data, we propose that NK cells are sentinel cells in a normal pancreas. We further speculate that during inflammation, pancreatic NK cells initially mediate proinflammatory effector functions, potentially contributing to organ-specific autoimmunity, but later become hyporesponsive because of exhaustion or regulation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20130214     DOI: 10.4049/jimmunol.0804358

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  37 in total

Review 1.  Immune cell crosstalk in type 1 diabetes.

Authors:  Agnès Lehuen; Julien Diana; Paola Zaccone; Anne Cooke
Journal:  Nat Rev Immunol       Date:  2010-07       Impact factor: 53.106

2.  Depletion of IL-2 receptor β-positive cells protects from diabetes in non-obese diabetic mice.

Authors:  Hanna Brauner; Håkan T Hall; Malin Flodström-Tullberg; Klas Kärre; Petter Höglund; Sofia Johansson
Journal:  Immunol Cell Biol       Date:  2015-08-05       Impact factor: 5.126

3.  Mature natural killer cells with phenotypic and functional alterations accumulate upon sustained stimulation with IL-15/IL-15Ralpha complexes.

Authors:  Kutlu G Elpek; Mark P Rubinstein; Angelique Bellemare-Pelletier; Ananda W Goldrath; Shannon J Turley
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-22       Impact factor: 11.205

4.  Insulinoma-released exosomes or microparticles are immunostimulatory and can activate autoreactive T cells spontaneously developed in nonobese diabetic mice.

Authors:  Huiming Sheng; Saleema Hassanali; Courtney Nugent; Li Wen; Emma Hamilton-Williams; Peter Dias; Yang D Dai
Journal:  J Immunol       Date:  2011-07-06       Impact factor: 5.422

5.  Circulating CD56+ cells of diabetic women show deviated homing potential for specific tissues during and following pregnancy.

Authors:  A V C Seaward; S D Burke; H Ramshaw; G N Smith; B A Croy
Journal:  Hum Reprod       Date:  2011-04-12       Impact factor: 6.918

Review 6.  Innate immunity and the pathogenesis of type 1 diabetes.

Authors:  Fabio Arturo Grieco; Francesco Vendrame; Isabella Spagnuolo; Francesco Dotta
Journal:  Semin Immunopathol       Date:  2010-04-10       Impact factor: 9.623

Review 7.  Thinking bedside at the bench: the NOD mouse model of T1DM.

Authors:  James C Reed; Kevan C Herold
Journal:  Nat Rev Endocrinol       Date:  2015-01-27       Impact factor: 43.330

Review 8.  Influence of host immunoregulatory genes, ER stress and gut microbiota on the shared pathogenesis of inflammatory bowel disease and Type 1 diabetes.

Authors:  Altin Gjymishka; Roxana M Coman; Todd M Brusko; Sarah C Glover
Journal:  Immunotherapy       Date:  2013-12       Impact factor: 4.196

Review 9.  The Expanding Role of Natural Killer Cells in Type 1 Diabetes and Immunotherapy.

Authors:  Chris Fraker; Allison L Bayer
Journal:  Curr Diab Rep       Date:  2016-11       Impact factor: 4.810

10.  Double negative (CD3+ 4- 8-) TCR alphabeta splenic cells from young NOD mice provide long-lasting protection against type 1 diabetes.

Authors:  Beverly Duncan; Cristina Nazarov-Stoica; Jacqueline Surls; Margaret Kehl; Constantin Bona; Sofia Casares; Teodor-D Brumeanu
Journal:  PLoS One       Date:  2010-07-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.